TCIM
EIGR
TIAA CREF Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-10,513
| Closed | -$120K | – | 3191 |
|
|
2017
Q1 | $120K | Hold |
10,513
| – | – | ﹤0.01% | 3032 |
|
|
2016
Q4 | $122K | Sell |
10,513
-273
| -3% | -$3.17K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $144 | Hold |
10,786
| – | – | ﹤0.01% | 3075 |
|
|
2016
Q2 | $214K | Buy |
+10,786
| New | +$214K | ﹤0.01% | 3084 |
|
|
2014
Q2 | – | Sell |
-21,486
| Closed | -$256K | – | 3187 |
|
|
2014
Q1 | $256K | Buy |
+21,486
| New | +$256K | ﹤0.01% | 3057 |
|